Diaveridine

HCID 21453

Basic information

CAS
5355-16-8
Standard SMILES
COc1ccc(Cc2cnc(N)nc2N)cc1OC
InChIKey
LDBTVAXGKYIFHO-UHFFFAOYSA-N
Molecular formula
C13H16N4O2
Average molar mass
260.29 g/mol
Monoisotopic mass
260.12732575

Overview

Diaveridine is an aminopyrimidine in which the pyrimidine ring carries amino substituents at C-2 and C-4 and a 3,4-dimethoxybenzyl group at C-5. A folic acid antagonist, it is used as a synergist with sulfonamides against the parasitic Eimeria species. It has a role as an antiparasitic agent and a drug allergen.

Names & identifiers

Preferred name
Diaveridine
IUPAC
5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
English name
Diaveridine
Molecular formula
C13H16N4O2
Molecular weight
260.29

Names & synonyms

DIAVERIDINE5355-16-8Diaveridin5-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamineDiaveridina2,4-Diamino-5-veratrylpyrimidineDiaveridinumBW 49-2102,4-Diamino-5-(3,4-dimethoxybenzyl)pyrimidineNSC-4087355-((3,4-Dimethoxyphenyl)methyl)-2,4-pyrimidinediamineDTXSID2046200
Show more names
DVDDIVERDINEDifenacegis5645dijunjinAI3-23935CCRIS-3784
7KVX81XA87CHEBI:1231152,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-BW-49210BW-49-2102,4-Pyrimidinediamine, 5-((3,4-dimethoxyphenyl)methyl)-DTXCID0026200RefChem:586320

Database identifiers

CAS
5355-16-8
PubChem CID
21453
DTXSID
DTXSID2046200
ChEMBL
CHEMBL19633
ChEBI
CHEBI:123115
UNII
7KVX81XA87
EC Number
226-333-3
Nikkaji
J9.549D

Properties

Computed structural properties

XLogP
1
Topological polar surface area
96.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
4
Heavy atoms
19

Experimental & physicochemical properties

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan

Physicochemical properties

Melting point
233 ° · 233°
Boiling point
506.1 · 506.1±60.0 °C(Predicted)
Density
1.252 · 1.252±0.06 g/cm3(Predicted)
storage temp.
2 · Keep in dark place,Inert atmosphere,2-8°C
solubility
DMSO (Slightly)
pka
7.11 · 7.11±0.10(Predicted)

Safety & regulation

GHS classification

GHS Classification · 4 items

Warning

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 46 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationDiaveridine: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (100%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
2
rtecs
UV8142000
hs_code
29335990
risk_code
36/37/38
Signal word
Warning

Chemistry & industry

Pharmacology

ATC CodeQP - Antiparasitic products, insecticides and repellents

Uses & manufacturing

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

Applications

UsesAntibacterial.

UsesDiaveridine is a dihydrofolate reductase inhibitor. It is used in veterinary medicine as a drug for its anticoccidial properties and its function as an antibacterial synergist.

Suppliers100 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
湖南韵邦生物科技股份有限公司85561037 15386497078 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
Shanghai Biolang Biotechnology Co., Ltd.+86-15970428662 +86-13397199602 · [email protected]
Additional notes · 1 item

DefinitionChEBI: An aminopyrimidine in which the pyrimidine ring carries amino substituents at C-2 and C-4 and a 3,4-dimethoxybenzyl group at C-5. A folic acid antagonist, it is used as a synergist with sulfonamides against the parasitic Eimeria species.

Related reactions

6 records

Compound notes

Loading…